Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: China Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20124
20134
20141
20152
20164
20173
20186
201910
202012
202113
20226
202311
202417
202516
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status49
Recruiting31
Completed17
Not yet recruiting16
Active, not recruiting7
Terminated2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Pulmonary Hospital, Shanghai, China9
Henan Cancer Hospital7
Peking University Cancer Hospital & Institute5
Zhejiang Cancer Hospital5
Hunan Province Tumor Hospital4
Sun Yat-sen University4
Chinese Academy of Medical Sciences3
Sichuan Baili Pharmaceutical Co., Ltd.3
Sichuan University3
Tianjin Medical University Cancer Institute and Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma125
Lung Neoplasms7
Recurrence4
Carcinoma, Non-Small-Cell Lung3
Carcinoma2
Colorectal Neoplasms2
Lung Diseases2
Stomach Neoplasms2
Thoracic Neoplasms2
Triple Negative Breast Neoplasms2

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.